Literature DB >> 33543393

Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.

Lihong Peng1, Xiaotong Hong1, Qingyu Yuan2, Lijun Lu3, Quanshi Wang4, Wufan Chen5.   

Abstract

OBJECTIVES: To develop a radiomics signature to predict locoregional recurrence (LR) and distant metastasis (DM), as extracted from pretreatment 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography/X-ray computed tomography (PET/CT) images in locally advanced nasopharyngeal carcinoma (NPC).
MATERIALS AND METHODS: Eighty-five patients with Stage III-IVB NPC underwent pretreatment [18F]FDG PET/CT scans and received radiotherapy or chemoradiotherapy. 53 of them achieved disease control, and 32 of them failed after treatment (15: LR, 17: DM). A total of 114 radiomic features were extracted from PET/CT images. For univariate analysis, Wilcoxon test and Chi-square test were used to compare median values of features between different treatment outcomes and predict the risk of treatment failure, respectively. For multivariate analysis, all features were grouped into clusters based on Pearson correlation using hierarchical clustering, and the representative feature of each cluster was chosen by the Relief algorithm. Then sequential floating forward selection (SFFS) coupled with a support vector machine (SVM) classifier were used to derive the optimized feature set in terms of the area under receiver operating characteristic (ROC) curve (AUC). The performance of the model was evaluated by leave-one-out-cross-validation, fivefold cross-validation, tenfold cross-validation.
RESULTS: Twenty features had significant differences between disease control and treatment failure. NPC patients with values of Compactness1, Compactness2, Coarseness_NGTDM or SGE_GLGLM above the median as well as patients with values of Irregularity, RLN_GLRLM or GLV_GLSZM below the median, showed a significant (p < 0.05) higher risk of treatment failure (about 50% vs. 25%). The derived radiomics signature consisted of 5 features with the highest AUC value of 0.8290 (sensitivity: 0.8438, specificity: 0.7736) using leave-one-out-cross-validation.
CONCLUSION: Locoregional recurrence (LR) and DM of locally advanced NPC can be predicted using radiomics analysis of pretreatment [18F]FDG PET/CT. The SFFS feature selection coupled with SVM classifier can derive the optimized feature set with correspondingly highest AUC value for pretreatment prediction of LR and/or DM of NPC.

Entities:  

Keywords:  Nasopharyngeal carcinoma; Prognosis; Radiomics; [18F]FDG PET/CT

Year:  2021        PMID: 33543393     DOI: 10.1007/s12149-021-01585-9

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  38 in total

1.  Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma--a retrospective review of 182 cases.

Authors:  T S Yang; K T Ng; H M Wang; C H Wang; C C Liaw; G M Lai
Journal:  Am J Clin Oncol       Date:  1996-08       Impact factor: 2.339

2.  High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.

Authors:  Xiang-bo Wan; Li Wei; Hao Li; Min Dong; Qu Lin; Xiao-kun Ma; Pei-yu Huang; Jing-yun Wen; Xing Li; Jie Chen; Dan-yun Ruan; Ze-xiao Lin; Zhan-hong Chen; Quentin Liu; Xiang-yuan Wu; Ming-huang Hong
Journal:  Eur J Cancer       Date:  2013-03-28       Impact factor: 9.162

3.  Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure.

Authors:  A W Lee; Y F Poon; W Foo; S C Law; F K Cheung; D K Chan; S Y Tung; M Thaw; J H Ho
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

4.  Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.

Authors:  Qiu-Yan Chen; Yue-Feng Wen; Ling Guo; Huai Liu; Pei-Yu Huang; Hao-Yuan Mo; Ning-Wei Li; Yan-Qun Xiang; Dong-Hua Luo; Fang Qiu; Rui Sun; Man-Quan Deng; Ming-Yuan Chen; Yi-Jun Hua; Xiang Guo; Ka-Jia Cao; Ming-Huang Hong; Chao-Nan Qian; Hai-Qiang Mai
Journal:  J Natl Cancer Inst       Date:  2011-11-04       Impact factor: 13.506

Review 5.  Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.

Authors:  Anne W M Lee; Brigette B Y Ma; Wai Tong Ng; Anthony T C Chan
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

6.  Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

Authors:  Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Wen-Miin Liang; Rong-San Jiang; Wen-Yi Wang
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

7.  Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma.

Authors:  Hong-Sheng Yu; Xin Wang; Ai-Qin Song; Ning Liu; Wei Zhang; Li Yu
Journal:  Asian Pac J Cancer Prev       Date:  2012

8.  Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

Authors:  Anne W M Lee; W M Sze; Joseph S K Au; S F Leung; T W Leung; Daniel T T Chua; Benny C Y Zee; Stephen C K Law; Peter M L Teo; Stewart Y Tung; Dora L W Kwong; W H Lau
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

9.  A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma.

Authors:  Jin-Gao Li; Xia Yuan; Ling-Ling Zhang; Yi-Qiang Tang; Lan Liu; Xiao-Dan Chen; Xiao-Chang Gong; Gui-Fen Wan; Yu-Lu Liao; Jian-Ming Ye; Fan Ao
Journal:  Cancer       Date:  2013-06-13       Impact factor: 6.860

10.  Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma.

Authors:  Xiao-Jing Du; Ling-Long Tang; Yan-Ping Mao; Rui Guo; Ying Sun; Ai-Hua Lin; Jun Ma
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

View more
  8 in total

Review 1.  Artificial intelligence for nuclear medicine in oncology.

Authors:  Kenji Hirata; Hiroyuki Sugimori; Noriyuki Fujima; Takuya Toyonaga; Kohsuke Kudo
Journal:  Ann Nucl Med       Date:  2022-01-14       Impact factor: 2.668

2.  Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.

Authors:  Adam A Dmytriw; Claudia Ortega; Reut Anconina; Ur Metser; Zhihui A Liu; Zijin Liu; Xuan Li; Thiparom Sananmuang; Eugene Yu; Sayali Joshi; John Waldron; Shao Hui Huang; Scott Bratman; Andrew Hope; Patrick Veit-Haibach
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

Review 3.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

4.  Prognostic Relevance of 18F-FDG-PET/CT-Guided Target Volume Delineation in Loco-Regionally Advanced Nasopharyngeal Carcinomas: A Comparative Study.

Authors:  Ouying Yan; Hui Wang; Yaqian Han; Shengnan Fu; Yanzhu Chen; Feng Liu
Journal:  Front Oncol       Date:  2021-08-23       Impact factor: 6.244

Review 5.  Radiomics in Nasopharyngeal Carcinoma.

Authors:  Wenyue Duan; Bingdi Xiong; Ting Tian; Xinyun Zou; Zhennan He; Ling Zhang
Journal:  Clin Med Insights Oncol       Date:  2022-02-24

6.  Radiomics based on pretreatment MRI for predicting distant metastasis of nasopharyngeal carcinoma: A preliminary study.

Authors:  Tingting Jiang; Yalan Tan; Shuaimin Nan; Fang Wang; Wujie Chen; Yuguo Wei; Tongxin Liu; Weifeng Qin; Fangxiao Lu; Feng Jiang; Haitao Jiang
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

7.  Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma.

Authors:  Yang Li; Meng Yu; Guangda Wang; Li Yang; Chongfei Ma; Mingbo Wang; Meng Yue; Mengdi Cong; Jialiang Ren; Gaofeng Shi
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

8.  Pretreatment Prediction of Relapse Risk in Patients with Osteosarcoma Using Radiomics Nomogram Based on CT: A Retrospective Multicenter Study.

Authors:  Jin Liu; Tao Lian; Haimei Chen; Xiaohong Wang; Xianyue Quan; Yu Deng; Juan Yao; Ming Lu; Qiang Ye; Qianjin Feng; Yinghua Zhao
Journal:  Biomed Res Int       Date:  2021-02-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.